# Exercise and Pioglitazone for HIV-Metabolic Syndromes

> **NCT00639457** · NA · COMPLETED · sponsor: **National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)** · enrollment: 44 (actual)

## Conditions studied

- HIV Infections
- Type 2 Diabetes
- Obesity
- HIV
- AIDS
- Cardiovascular Disease
- Lipodystrophy

## Interventions

- **DRUG:** Pioglitazone
- **BEHAVIORAL:** Exercise training

## Key facts

- **NCT ID:** NCT00639457
- **Lead sponsor:** National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- **Sponsor class:** NIH
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-01
- **Primary completion:** 2008-12
- **Final completion:** 2009-12
- **Target enrollment:** 44 (ACTUAL)
- **Last updated:** 2013-10-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00639457

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00639457, "Exercise and Pioglitazone for HIV-Metabolic Syndromes". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00639457. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*